Purpose: The aim of this study was to analyze the effects of corneal crosslinking (CXL) combined with phototherapeutic keratectomy (PTK) and photorefractive keratectomy (PRK) in halting the progression and improving the visual function of corneal ectasia after laser in situ keratomileusis (LASIK). Methods: PTK-PRK-CXL was performed on 14 eyes of 14 patients who developed corneal ectasia after LASIK. The visual acuity, spherical refraction and cylinder, corneal topography indices, thinnest corneal thickness (TCT), and endothelial cell count were evaluated at baseline and at 1, 3, 6, and 12 months postoperatively. Results: The mean uncorrected visual acuity improved significantly from 0.64 ± 0.36 logMAR preoperatively to 0.19 ± 0.12 logMAR at 12 months of follow-up (p < 0.001), while the mean best corrected visual acuity improved from 0.21 ± 0.14 logMAR at baseline to 0.04 ± 0.10 logMAR at 12 months postoperatively (p < 0.001). A significant decrease was observed in Kmax and Kmean values from 52.51 ± 6.74 and 43.55 ± 3.37 D at baseline to 45.72 ± 5.18 (p < 0.001) and 40.60 ± 3.05 D (p < 0.001) at the 1-year follow-up. The mean TCT decreased significantly from 419.07 ± 36.56 µm before treatment to 320.93 ± 39.78 µm at 12 months of follow-up (p < 0.001), and there was no significant endothelial cell loss (p > 0.05) beyond 6 months after treatment. Conclusion: PTK-PRK-CXL is a promising procedure to halt the progression of post-LASIK keratectasia with significant visual quality improvement.

1.
Seiler T, Koufala K, Richter G: Iatrogenic keratectasia after laser in situ keratomileusis. J Refract Surg 1998;14:312-317.
2.
Randleman JB, Russell B, Ward MA, Thompson KP, Stulting RD: Risk factors and prognosis for corneal ectasia after LASIK. Ophthalmology 2003;110:267-275.
3.
Hafezi F, Kanellopoulos J, Wiltfang R, Seiler T: Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J Cataract Refract Surg 2007;33:2035-2040.
4.
Salgado JP, Khoramnia R, Lohmann CP, Winkler von Mohrenfels C: Corneal collagen crosslinking in post-LASIK keratectasia. Br J Ophthalmol 2011;95:493-497.
5.
Hersh PS, Greenstein SA, Fry KL: Corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg 2011;37:149-160.
6.
Asri D, Touboul D, Fournié P, et al: Corneal collagen crosslinking in progressive keratoconus: multicenter results from the French National Reference Center for Keratoconus. J Cataract Refract Surg 2011;37:2137-2143.
7.
Caporossi A, Mazzotta C, Baiocchi S, Caporossi T: Long-term results of riboflavin ultraviolet A corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol 2010;149:585-593.
8.
Kapasi M, Baath J, Mintsioulis G, Jackson WB, Baig K: Phototherapeutic keratectomy versus mechanical epithelial removal followed by corneal collagen crosslinking for keratoconus. Can J Ophthalmol 2012;47:344-347.
9.
Kymionis GD, Grentzelos MA, Kounis GA, Diakonis VF, Limnopoulou AN, Panagopoulou SI: Combined transepithelial phototherapeutic keratectomy and corneal collagen cross-linking for progressive keratoconus. Ophthalmology 2012;119:1777-1784.
10.
Kymionis GD, Grentzelos MA, Kankariya VP, Pallikaris IG: Combined transepithelial phototherapeutic keratectomy and corneal collagen crosslinking for ectatic disorders: Cretan protocol. J Cataract Refract Surg 2013;39:1939.
11.
Hafezi F, Mrochen M, Iseli HP, Seiler T: Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas. J Cataract Refract Surg 2009;35:621-624.
12.
Randleman JB: Ectasia after LASIK: new treatments, new hope. J Refract Surg 2011;27:319.
13.
Wollensak G, Spoerl E, Seiler T: Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003;135:620-627.
14.
Vinciguerra P, Camesasca FI, Albè E, Trazza S: Corneal collagen cross-linking for ectasia after excimer laser refractive surgery: 1-year results. J Refract Surg 2010;26:486-497.
15.
Cennamo G, Intravaja A, Boccuzzi D, Marotta G: Treatment of keratoconus by topography-guided customized photorefractive keratectomy: two-year follow-up study. J Refract Surg 2008;24:145-149.
16.
Kapasi M, Dhaliwal A, Mintsioulis G, Jackson WB, Baig K: Long-term results of phototherapeutic keratectomy versus mechanical epithelial removal followed by corneal collagen cross-linking for keratoconus. Cornea 2016;35:157-161.
17.
Kymionis GD, Grentzelos MA, Kankariya VP, et al: Long-term results of combined transepithelial phototherapeutic keratectomy and corneal collagen crosslinking for keratoconus: Cretan protocol. J Cataract Refract Surg 2014;40:1439-1445.
18.
Kymionis GD, Kontadakis GA, Kounis GA, et al: Simultaneous topography-guided PRK followed by corneal collagen cross-linking for keratoconus. J Refract Surg 2009;25:807-811.
19.
Kanellopoulos AJ, Binder PS: Management of corneal ectasia after LASIK with combined, same-day, topography-guided partial transepithelial PRK and collagen cross-linking: the Athens protocol. J Refract Surg 2011;27:323-331.
20.
Kontadakis GA, Kankariya VP, Tsoulnaras K, Pallikaris AI, Plaka A, Kymionis GD: Long-term comparison of simultaneous topography-guided photorefractive keratectomy followed by corneal cross-linking versus corneal cross-linking alone. Ophthalmology 2016;123:974-983.
21.
Greenstein SA, Shah VP, Fry KL, Hersh PS: Corneal thickness changes after corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg 2011;37:691-700.
22.
Schmack I, Dawson DG, McCarey BE, et al: Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations. J Refract Surg 2005;21:433-445.
23.
Kymionis GD, Portaliou DM, Diakonis VF, Kounis GA, Panagopoulou SI, Grentzelos MA: Corneal collagen cross-linking with riboflavin and ultraviolet-A irradiation in patients with thin corneas. Am J Ophthalmol 2012;153:24-28.
24.
Mooren P, Gobin L, Bostan, et al: Evaluation of UVA cytotoxicity for human endothelium in an ex vivo corneal cross-linking experimental setting. J Refract Surg 2016;32:135.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.